Wells Fargo Maintains Overweight on IDEAYA Biosciences, Raises Price Target to $48

Benzinga Newsdesk www.benzinga.com Positive 81.5%

Neg 0% Neu 0% Pos 81.5%

Wells Fargo analyst Eva Fortea Verdejo maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight and raises the price target from $44 to $48.